Lupin acquires diabetes trademarks from Boehringer Ingelheim to bolster treatment portfolio
Lupin Limited, a global pharmaceutical leader based in Mumbai, has announced the acquisition of three anti-diabetes trademarks—GIBTULIO, GIBTULIO MET, and AJADUO—from Boehringer Ingelheim International GmbH. ... Read More
Lupin partners with Takeda to launch novel gastrointestinal drug Vonoprazan in India
In a significant development, Lupin Limited, a global pharmaceutical leader, announced a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Limited to commercialise Vonoprazan Tablets ... Read More
New drug launch sends Lupin shares soaring to record highs! Find out what’s next
Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch of its generic Mirabegron Extended-Release Tablets, 50 ... Read More
Lupin Limited sees explosive profit surge in Q1 FY2025
Lupin Limited has reported a remarkable financial performance for the quarter ending June 30, 2024. The pharmaceutical giant's sales for Q1 FY2025 reached INR 55,143 ... Read More
Big pharma shakeup: Lupin sells women’s health arm for mega millions
Lupin Limited, a global pharmaceutical leader, has officially divested its U.S. Commercial Women’s Health Specialty Business to Evofem Biosciences, Inc., a company specializing in women's ... Read More
Lupin Limited secures major victory: A perfect FDA score for its Gujarat plant
Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). ... Read More
Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief Executive Officer of its newly established subsidiary, ... Read More
Lupin Limited expands global specialty portfolio with strategic acquisitions
Global pharmaceutical leader Lupin Limited (Lupin) has announced the completion of a strategic acquisition through its European hub, Lupin Atlantis Holdings SA. The company has ... Read More
Lupin Limited appoints Christoph Funke as Chief Technical Operations Officer to spearhead global pharmaceutical operations
Lupin Limited, a global leader in the pharmaceutical industry, announced today the strategic appointment of Christoph Funke to the newly created role of Chief Technical ... Read More
Lupin Limited secures FDA approval for generic Bromfenac Ophthalmic Solution
In a significant development for the global pharmaceutical industry, Lupin Limited (Lupin) has announced its latest achievement: receiving approval from the United States Food and ... Read More